product
Company logo
product
BioEcolia®
Search in

Producer: 
Solabia Group
Brand: 
BioEcolia
BioEcolia® is a glucan oligosaccharide obtained by enzymatic synthesis from natural sugars (sucrose and maltose). This product is used for the protection and biostimulation of natural skin defenses. It is a bioselective substrate for beneficial microbial flora, Ecoflora, to the detriment of pathogens and undesirable flora. It offers gentle protective and restoring action for all types of skin and the scalp.

BioEcolia®

Producer: 
Solabia Group
Brand: 
BioEcolia
BioEcolia® is a glucan oligosaccharide obtained by enzymatic synthesis from natural sugars (sucrose and maltose). This product is used for the protection and biostimulation of natural skin defenses. It is a bioselective substrate for beneficial microbial flora, Ecoflora, to the detriment of pathogens and undesirable flora. It offers gentle protective and restoring action for all types of skin and the scalp.
Take Action

Experts (1)

Knowde Enhanced TDS

Expand All

+

Features & Benefits

+
End Use Claims
Protection
Origin
Biotechnology
Mechanism of Action

Bioecolia® is a recognized prebiotic dedicated to the preservation of the protective ecosystem (microbiota) of the skin, mucous membranes and scalp:

  • it stimulates, in a bioselective way, the development of the beneficial flora to the detriment of pathogenic and undesirable flora.
  • it stimulates the production of anti-microbial peptides, key immunological markers, essential for maintaining microbial balance.

Usually the effect of glucooligosaccharides is limited to this bioselectivity only. The research of the Solabia group has detected and patented these molecules, and in particular Bioecolia®, which could also have immunostimulant properties that favor the expression and synthesis of anti-microbial peptides in the skin.

This capacity can be explained by several hypotheses and routes:
- they activate the capacity of commensal bacteria to induce the expression of anti-microbial peptides via the stimulation of the development of the beneficial Ecoflora.
- they induce the expression of anti-microbial peptides via the interaction with keratinocyte immunologic receptors
- they constitute a cell-cell communication path, via the binding of keratinocyte membrane lectins, which is capable of activating signalization paths that could lead to the production of anti-microbial antibodies.

Applications & Uses

+
Application Format
Hair Care Applications
Use Level
0.25-3%
Recommended Uses
  • Care products for all healthy skin types – preventive effect
  • Care products for babies and young children
  • Care products for acne-prone skins
  • Care products for sensitive or even atopic-prone skins
  • Intimate care and hygiene products
     

Properties

+
Ingredient Origin
Physical Form
Physical Form
Powder
Color
White

Regulatory & Compliance

+
Certifications
Regulatory Status

Authorized for use in EU, USA, Japan, China (IECIC 2015 and IECSC) and subject to conditions in Australia and Canada

Technical Details & Test Data

+
Efficacy Studies

Stimulation of Beneficial Flora

1. Selective Metabolism

In vitro study. Incubation (48h) of saprophytic and pathogenic strains, in a reference culture medium containing 0.5% or 3% carbonated substrate (BIOECOLIA® vs glucose). Determination of the quantity of residual substrate.

2. Growth inhibition of cutaneous yeast

In vitro study. Incubation (24h) of strains in a culture medium (tryptone salt) supplemented by 0.5% or 1% BIOECOLIA®. Counting on Sabouraud agar.

Result : No growth of Malassezia furfur and Candida albicans

3. Competitive inhibition

In vitro study. Simultaneous inoculation of M. kristinae (saprophytic flora) and S. aureus (pathogenic flora) or C. xerosis (undesirable flora) in a liquid culture medium containing 0.5% BIOECOLIA®. Bacterial counting on a specific medium after 24h.

Result: Stimulation of the bacterial growth of the beneficial flora to the detriment of undesirable/pathogenic flora

Stimulation of Anti-Microbial Defenses

Stimulation of β-Defensin 2 & 3 : Ex vivo study on skin explants treated with 0.25% or 0.75% BIOECOLIA® in culture medium vs untreated control. At D7, quantification of hBD2 and hBD3 by immunolabeling.

Result: At 0.75%, Bioecolia® stimulates β-defensin 2 & 3 by +75% and +153% after 7 days

 

Packaging & Availability

+
Regional Availability

Documents (2)

Name
Type
FDS_MSDS_BIOECOLIA®_AC033_EN
Safety Data Sheet
Bioecolia - Product sheet V6
Technical Data Sheet